Gidre LICENSE FORM
To obtain the right to copy Gidre , fill out the
user information columns
at the last of this license sheet and send it to us.
Once you have sent the signed license form, you may copy Gidre .
You do not have to wait for receipt of the signed form.
The Special Interest Group in Gidre (SIG-memb )
(hereinafter referred to as SIG) grants to the user whose name is
(hereinafter referred to as USER), a non-transferable and non-exclusive
license to copy and use Gidre under the following terms and
conditions and for the period of time identified in Paragraph
- This license agreement grants to the USER the right to use
Gidre within their own home or organization. The USER may make
copies of Gidre for use within their own home or organization,
but may not further distribute Gidre except as provided in
- SIG intends that Gidre be widely
distributed and used, but in a manner which preserves the
quality and integrity of Gidre . The USER may
send a copy of Gidre to another home or organization only
after either receiving permission from SIG or after seeing
written evidence that the other home or organization has signed
this agreement and sent a hard copy of it to SIGGidre.
If the USER wants to make modifications to Gidre and wants to
modified copy, the USER will first obtain permission from SIG by written
or electronic communication. Any USER which has received such a modified
copy can pass it on as received, but must receive further permission for
further modifications. All modifications to copies of Gidre
passed on to other homes or organizations shall be clearly and
conspicuously indicated in all such copies. Under no other
circumstances than provided in this paragraph shall a modified copy
of Gidre be represented as Gidre .
- The USER will ensure that all their copies of Gidre , whether
modified or not, carry as the first information item the following
© Kagehiko Kitano and Human Genome Center , 1994.
All rights reserved.
Copying of this file is authorized to users who have executed the true and
proper "License Agreement for Gidre " with SIGGidre.
- Title to and ownership of Gidre and its copies shall at all
times remain with SIG and those admitted by SIG as
contributors to the development of Gidre . The USER will return
to SIG for further distribution modifications to Gidre ,
modifications being understood to mean changes which
increase the speed, reliability and existing functionality of the software
delivered to the USER. The USER may make for their own ownership and use
enhancements to Gidre which add new functionality and
applications which employ Gidre .
Such modules may be returned to SIG at the option of the USER.
- Gidre IS LICENSED WITH NO WARRANTY OF ANY KIND.
SIG WILL NOT BE RESPONSIBLE FOR THE CORRECTION OF ANY BUGS OR
OTHER DEFICIENCIES. IN NO EVENT SHALL SIG BE LIABLE FOR ANY
DAMAGES OF ANY KIND, INCLUDING SPECIAL, INDIRECT OR CONSEQUENTIAL
DAMAGES, ARISING OUT OF OR IN CONNECTION WITH THE USE OR PERFORMANCE
OF Gidre .
- This license for Gidre shall be
effective from the date hereof and shall remain in force until
the USER discontinues use of Gidre . In the event the USER
neglects or fails to perform or observe any obligations under
this Agreement, this Agreement and the License granted hereunder
shall be immediately terminated and the USER shall certify to
SIG in writing that all copies of Gidre in whatever form
in its possession or under its control have been destroyed.
- Requests. Gidre is provided by SIG in a spirit of
friendship and cooperation. SIG asks that people enjoying
the use of Gidre cooperate in return to help further develop
and distribute Gidre . Specifically, SIG would like to
know which machines Gidre gets used on. A brief notice form is
appended to this agreement which the user is requested to send by email or
otherwise. Please send in further notifications at reasonable intervals if
you increase the number and type of machines on which Gidre is
loaded. You may send these notices to another USER which is
cooperating with SIG for this purpose.
BY: Kagehiko Kitano
Human Genome Center,
Institute of Medical Science, The University of Tokyo
4-6-1 Shirokanedai, Minato-ku, Tokyo 108, JAPAN
BY: Toshihisa Takagi
Director of the Genome Database Area,
Human Genome Center, Institute of Medical Science,
The University of Tokyo
4-6-1 Shiroganedai, Minato-ku, Tokyo 108, JAPAN